Page 5 - Generation Bio News Today

Generation Bio Co. (GBIO) delivered earnings and revenue surprises of 4.08% and 88.27%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

The recent 11% drop in Generation Bio Co.'s ( NASDAQ:GBIO ) stock could come as a blow to insiders who purchased...

Generation Bio Co. (NASDAQ:GBIO – Free Report) has been given a consensus recommendation of “Moderate Buy” by the six brokerages that are covering the firm, MarketBeat Ratings reports. One research analyst has rated the stock with a hold rating and five have assigned a buy rating to the company. The average 12 month price objective […]

Generation Bio Co. (NASDAQ:GBIO – Free Report) insider Phillip Samayoa sold 3,116 shares of the business’s stock in a transaction dated Monday, July 3rd. The stock was sold at an average price of $5.29, for a total value of $16,483.64. Following the sale, the insider now owns 101,428 shares in the company, valued at approximately […]

Dr. Zhong Zhong joins Ovid as Chief Scientific Officer (CSO) and Dr. Manoj Malhotra assumes role as Chief Medical Officer (CMO) following the planned retirement of Dr. Claude NicaiseMeg Alexander promoted to Chief Strategy OfficerOvid streamlined G&A ...

Generation Bio Co. (NASDAQ:GBIO – Get Rating) was the target of a large growth in short interest during the month of May. As of May 31st, there was short interest totalling 2,250,000 shares, a growth of 6.6% from the May 15th total of 2,110,000 shares. Based on an average daily trading volume, of 439,000 shares, […]

Shares of Generation Bio Co. (NASDAQ:GBIO – Get Rating) have received an average recommendation of “Moderate Buy” from the six research firms that are presently covering the stock, MarketBeat reports. One equities research analyst has rated the stock with a hold rating and five have assigned a buy rating to the company. The average 1 […]

Generation Bio Co. (NASDAQ:GBIO – Get Rating) has been given a consensus recommendation of “Moderate Buy” by the six brokerages that are presently covering the company, Marketbeat reports. One research analyst has rated the stock with a hold recommendation and five have given a buy recommendation to the company. The average 12-month price objective among […]

CAMBRIDGE, Mass., May 31, 2023 -- Generation Bio Co. , a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases, announced that Geoff McDonough, M.D.,... | May 31, 2023

GENERATION BIO CO. (NASDAQ:GBIO) : Stock quote, stock chart, quotes, analysis, advice, financials and news for share GENERATION BIO CO. | Nasdaq: GBIO | Nasdaq